Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03739684 | Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer(CONDOR) | completed | Phase 3 | 208 | Progenics Pharmaceuticals, Inc.INDUSTRY | 2 | Jun 14, 2021 | clinicaltrials |
| NCT02834416 | ADT Exercise Trial and Economic Analysis(ADTExRCT) | completed | Phase 3 | 38 | University Health Network, TorontoOTHER | 1 | Apr 13, 2021 |
| clinicaltrials |
| NCT02111577 | Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer(VIABLE) | completed | Phase 3 | 1,182 | SOTIO a.s.INDUSTRY | 22 | Apr 6, 2021 | clinicaltrials |
| NCT01538628 | SpaceOAR System Pivotal Study | completed | Phase 3 | 222 | Boston Scientific CorporationINDUSTRY | 1 | Mar 19, 2021 | clinicaltrials |
| NCT00010244 | Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer | completed | Phase 3 | 306 | UNICANCEROTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT00104715 | Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer | completed | Phase 3 | 385 | UNICANCEROTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT03404648 | Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI | completed | Phase 3 | 19 | Mayo ClinicOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT03911310 | [18F]PSMA-11 PET/CT Phase 3 Clinical Study(NGP3) | completed | Phase 3 | 96 | University Hospital, GhentOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT02919111 | Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients(PSMA PreRP) | completed | Phase 2 / Phase 3 | 299 | University of California, San FranciscoOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT02175212 | Clinical Trials of Adjuvant Androgen Deprivation in Localized Prostate Cancer(AADLPC) | completed | Phase 3 | 362 | Fundación de Investigación Biomédica - Hospital Universitario de La PrincesaOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT00004054 | Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 397 | Radiation Therapy Oncology GroupNETWORK | 2 | Oct 22, 2020 | clinicaltrials |
| NCT00023829 | Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer | completed | Phase 3 | 67 | Radiation Therapy Oncology GroupNETWORK | 1 | Oct 22, 2020 | clinicaltrials |
| NCT00030654 | Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 21 | Radiation Therapy Oncology GroupNETWORK | 4 | Oct 22, 2020 | clinicaltrials |
| NCT02887976 | Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201 | completed | Phase 3 | 2 | GU Research Network, LLCOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT01168479 | FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer(FLAME) | completed | Phase 3 | 571 | UMC UtrechtOTHER | 2 | Jun 2, 2020 | clinicaltrials |
| NCT00079001 | Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases | completed | Phase 3 | 645 | Alliance for Clinical Trials in OncologyOTHER | 2 | May 12, 2020 | clinicaltrials |
| NCT03261999 | Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer | completed | Phase 3 | 144 | Foresee Pharmaceuticals Co., Ltd.INDUSTRY | 5 | May 4, 2020 | clinicaltrials |
| NCT00002633 | Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 361 | NCIC Clinical Trials GroupNETWORK | 1 | Apr 3, 2020 | clinicaltrials |
| NCT00003232 | Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer | completed | Phase 3 | 227 | NCIC Clinical Trials GroupNETWORK | 1 | Apr 3, 2020 | clinicaltrials |
| NCT00064194 | Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia | completed | Phase 3 | 310 | NCIC Clinical Trials GroupNETWORK | 1 | Apr 3, 2020 | clinicaltrials |
| NCT01212991 | A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer(PREVAIL) | completed | Phase 3 | 1,717 | PfizerINDUSTRY | 22 | Mar 17, 2020 | clinicaltrials |
| NCT00007644 | Prostate Cancer Intervention Versus Observation Trial (PIVOT)(PIVOT) | completed | Phase 3 | 731 | VA Office of Research and DevelopmentFED | 1 | Feb 24, 2020 | clinicaltrials |
| NCT01591122 | Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer | completed | Phase 3 | 313 | Janssen Research & Development, LLCINDUSTRY | 4 | Jan 21, 2020 | clinicaltrials |
| NCT02260817 | Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer | completed | Phase 3 | 109 | Global Isotopes, LLC d/b/a Zevacor MolecularINDUSTRY | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01715129 | Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer(DKP 3M SC) | completed | Phase 3 | 126 | IpsenINDUSTRY | 5 | Dec 9, 2019 | clinicaltrials |
| NCT02918357 | Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence(PSMA BCR) | completed | Phase 2 / Phase 3 | 385 | University of California, San FranciscoOTHER | 1 | Dec 2, 2019 | clinicaltrials |
| NCT02578940 | Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer(FALCON) | completed | Phase 3 | 104 | Blue Earth DiagnosticsINDUSTRY | 1 | Oct 7, 2019 | clinicaltrials |
| NCT04056754 | Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer | completed | Phase 3 | 268 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Aug 14, 2019 | clinicaltrials |
| NCT01695135 | A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy | completed | Phase 3 | 214 | Janssen Research & Development, LLCINDUSTRY | 1 | Jul 18, 2019 | clinicaltrials |
| NCT01310894 | Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.(PCM301) | completed | Phase 3 | 413 | Steba Biotech S.A.OTHER | 10 | Jul 11, 2019 | clinicaltrials |
| NCT01006395 | Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT) | completed | Phase 2 / Phase 3 | 64 | Austin HealthOTHER_GOV | 1 | Jul 5, 2019 | clinicaltrials |
| NCT02085252 | A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer | completed | Phase 3 | 116 | TakedaINDUSTRY | 1 | Jun 28, 2019 | clinicaltrials |
| NCT00255125 | Role of Soy Supplementation in Prostate Cancer Development | completed | Phase 3 | 86 | VA Office of Research and DevelopmentFED | 1 | Jun 18, 2019 | clinicaltrials |
| NCT01308567 | Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer(FIRSTANA) | completed | Phase 3 | 1,168 | SanofiINDUSTRY | 25 | Jun 5, 2019 | clinicaltrials |
| NCT01707966 | Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy | completed | Phase 3 | 47 | Swiss Cancer InstituteOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT02615067 | Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer(proSPECT-AS) | completed | Phase 3 | 531 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 2 | Apr 10, 2019 | clinicaltrials |
| NCT02712320 | Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg | completed | Phase 3 | 30 | Foresee Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Mar 26, 2019 | clinicaltrials |
| NCT02234115 | Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma | completed | Phase 3 | 137 | Foresee Pharmaceuticals Co., Ltd.INDUSTRY | 8 | Mar 5, 2019 | clinicaltrials |
| NCT01020448 | Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer(Triptocare) | completed | Phase 3 | 339 | IpsenINDUSTRY | 10 | Jan 30, 2019 | clinicaltrials |
| NCT02680041 | 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment(LOCATE) | completed | Phase 3 | 221 | Blue Earth DiagnosticsINDUSTRY | 1 | Jan 28, 2019 | clinicaltrials |
| NCT01193257 | Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer. | completed | Phase 3 | 1,099 | Millennium Pharmaceuticals, Inc.INDUSTRY | 14 | Dec 19, 2018 | clinicaltrials |
| NCT00974311 | Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy(AFFIRM) | completed | Phase 3 | 1,199 | PfizerINDUSTRY | 15 | Dec 11, 2018 | clinicaltrials |
| NCT02551341 | Lung Protective Ventilation During Robotic Assisted Prostatectomy | completed | Phase 3 | 24 | Jørgen Bjerggaard JensenOTHER | 1 | Nov 16, 2018 | clinicaltrials |
| NCT00002855 | Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer | completed | Phase 3 | 306 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT00838201 | Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer | completed | Phase 3 | 384 | AmgenINDUSTRY | 6 | Oct 18, 2018 | clinicaltrials |
| NCT00089674 | AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer | completed | Phase 3 | 1,468 | AmgenINDUSTRY | 0 | Oct 17, 2018 | clinicaltrials |
| NCT01810770 | Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis | completed | Phase 3 | 243 | BayerINDUSTRY | 4 | Sep 19, 2018 | clinicaltrials |
| NCT02840552 | The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer | completed | Phase 3 | 60 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT00132301 | Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma(CAP) | completed | Phase 3 | 298 | VA Office of Research and DevelopmentFED | 2 | Jun 25, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Jun 14, 2021source: clinicaltrials